Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit while applying deeper, domain-specific diligence to early stage bets.

NEW YORK, NY--(Marketwired - Jun 5, 2013) - Mid Atlantic Bio Angels (MABA) today announced their first investment of $500,000 in Cerus Endovascular Ltd, a company that has developed a minimally ...

In this episode of Denatured, you'll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, ...

If Monday night’s Biography special on the Guardian Angels catches the right eyeballs, we could soon have a Guardian Angels “reality” show. And hey, why not? It would hardly be the worst entry in the ...

Yaniv Sneor is the co-founder of Mid Atlantic Bio Angels and is taking part in Ask the Investor sessions at MedCity INVEST this week. Healthcare and life science startups have the opportunity to ...

NEW YORK, NY, USA, March 30, 2023/EINPresswire.com/ -- Mid Atlantic Bio Angels, a NY-based angel investor group, is investing in Hilltop Bio, a veterinary biotech ...

GROSSE POINTE, Mich., Feb. 3, 2026 /PRNewswire/ -- Ecovia Bio, an advanced biotechnology company specializing in sustainable, high-performance biopolymer ingredients, today announced the closing of a ...

NEW YORK, NY--(Marketwired - Oct 17, 2013) - Mid Atlantic Bio Angels (MABA) today announced a $400,000 investment in Immunomic Therapeutics, a clinical stage vaccine platform technology company and ...